Posted on December 26, 2012
Patients who have inherited a specific common genetic variant develop bladder cancer tumors that strongly express a protein known as prostate stem cell antigen (PSCA), which is also expressed in many pancreatic and prostate tumors, according to research at the National Institutes of Health. The study appeared in the Journal of the National Cancer Institute, December 26, 2012.
The National Cancer Institute (NCI) press release for the study
News article in NCI’s bi-weekly newsletter the Cancer Bulletin
To request an interview with a DCEG investigator, contact the NCI Office of Media Relations:
E-mail:
ncipressofficers@mail.nih.gov
Phone: 301-496-6641